ABBV is trading at $218.60 (-4.67%), diverging sharply from broader market gains as no specific news or event explains the sudden decline.
- The decline occurs despite strong market performance (Dow up 1.38%, S&P 500 up 0.75%, and NASDAQ up 0.85%).
- The drop is attributed to likely sector rotation or profit-taking following recent stability around $229.
- No ABBV-specific earnings or events were reported; the only scheduled item was a routine J.P. Morgan Healthcare Conference presentation announcement.